Cytokine IL‑6 is required in Citrobacter rodentium infection‑induced intestinal Th17 responses and promotes IL‑22 expression in inflammatory bowel disease

Mundy R, MacDonald TT, Dougan G, Frankel G and Wiles S: Citrobacter rodentium of mice and man. Cell Microbiol. 7:1697–1706. 2005. View Article : Google Scholar

Luperchio SA and Schauer DB: Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3:333–340. 2001.

Borenshtein D, McBee ME and Schauer DB: Utility of the Citrobacter rodentium infection model in laboratory mice. Curr Opin Gastroenterol. 24:32–37. 2008.

Kim YG, Kamada N, Shaw MH, Warner N, Chen GY, Franchi L and Núñez G: The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity. 34:769–780. 2011. View Article : Google Scholar : PubMed/NCBI

Johnson E and Barthold SW: The ultrastructure of transmissible murine colonic hyperplasia. Am J Pathol. 97:291–313. 1979.PubMed/NCBI

Morgan ET, Goralski KB, Piquette-Miller M, et al: Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos. 36:205–216. 2008. View Article : Google Scholar : PubMed/NCBI

Neurath MF, Weigmann B, Finotto S, et al: The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn’s disease. J Exp Med. 195:1129–1143. 2002.PubMed/NCBI

Nenci A, Becker C, Wullaert A, et al: Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 446:557–561. 2007. View Article : Google Scholar : PubMed/NCBI

Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C and Vallance BA: MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol. 10:618–631. 2008. View Article : Google Scholar : PubMed/NCBI

Gibson DL, Ma C, Rosenberger CM, et al: Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol. 10:388–403. 2008.PubMed/NCBI

Lebeis SL, Bommarius B, Parkos CA, Sherman MA and Kalman D: TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol. 179:566–577. 2007. View Article : Google Scholar : PubMed/NCBI

Eckmann L: Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci. 1072:28–38. 2006. View Article : Google Scholar : PubMed/NCBI

Vallance BA, Deng W, Knodler LA and Finlay BB: Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect Immun. 70:2070–2081. 2002. View Article : Google Scholar

Shiomi H, Masuda A, Nishiumi S, et al: Gamma interferon produced by antigen-specific CD4⁺ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Infect Immun. 78:2653–2666. 2010. View Article : Google Scholar : PubMed/NCBI

Bry L and Brenner MB: Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol. 172:433–441. 2004. View Article : Google Scholar : PubMed/NCBI

Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA and Artis D: CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity. 34:122–134. 2011.

Ishigame H, Kakuta S, Nagai T, et al: Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 30:108–119. 2009. View Article : Google Scholar : PubMed/NCBI

Ivanov II, Atarashi K, Manel N, et al: Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 139:485–498. 2009. View Article : Google Scholar : PubMed/NCBI

Chiricozzi A, Guttman-Yassky E, Suarez-Fariñas M, et al: Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol. 131:677–687. 2011.

Geddes K, Rubino SJ, Magalhaes JG, et al: Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med. 17:837–844. 2011. View Article : Google Scholar : PubMed/NCBI

Miossec P, Korn T and Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med. 361:888–898. 2009. View Article : Google Scholar : PubMed/NCBI

O’Dell JR, Elliott JR, Mallek JA, et al: Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum. 54:621–627. 2006.PubMed/NCBI

Sartor RB: Microbial influences in inflammatory bowel diseases. Gastroenterology. 134:577–594. 2008. View Article : Google Scholar : PubMed/NCBI

Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ and Powrie F: Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 464:1371–1375. 2010. View Article : Google Scholar : PubMed/NCBI

Hirota K, Turner JE, Villa M, Duarte JH, Demengeot J, Steinmetz OM and Stockinger B: Plasticity of TH17 cells in Peyer’s patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol. 14:372–379. 2013.